Treatment of Cough Due to Community-Acquired Pneumonia in Healthy Adult Outpatients
For an otherwise healthy adult outpatient with cough due to community-acquired pneumonia, treat empirically with oral antibiotics covering Streptococcus pneumoniae and atypical pathogens for a minimum of 5 days, ensuring the patient is afebrile for 48-72 hours before stopping therapy. 1
Antibiotic Selection
First-Line Options for Healthy Outpatients
- Amoxicillin is the first-choice antibiotic for outpatient management when no risk factors for resistant organisms are present 1
- Macrolides (azithromycin or clarithromycin) are appropriate alternatives, particularly effective against atypical pathogens like Mycoplasma pneumoniae 1, 2
- Respiratory fluoroquinolones (levofloxacin 750 mg daily or moxifloxacin) are highly effective alternatives with >90% clinical success rates and provide coverage for both typical and atypical pathogens 2, 3
Specific Dosing Recommendations
- Levofloxacin 750 mg orally once daily for 5 days is an evidence-based short-course regimen with equivalent efficacy to longer courses 4
- Azithromycin 500 mg daily for 3 days represents an effective short-course macrolide option 5
- Amoxicillin-clavulanate should be used if beta-lactamase-producing Haemophilus influenzae is common in your area or if the patient has chronic lung disease 1
Treatment Duration
- Minimum 5 days of antibiotic therapy is required for all patients with community-acquired pneumonia 1
- Patient must be afebrile for 48-72 hours and have no more than one sign of clinical instability before discontinuing antibiotics 1
- Usual practice is 5-7 days for uncomplicated cases managed at home 1
- Inform patients that cough may persist beyond the antibiotic course and does not necessarily indicate treatment failure 1
Clinical Assessment Before Treatment
Symptoms and Signs Suggesting Pneumonia
- Presence of cough, dyspnea, pleural pain, sweating/fevers/shivers, temperature ≥38°C, tachypnea, and new localizing chest examination signs strongly suggest pneumonia 1
- Absence of runny nose combined with breathlessness, crackles, diminished breath sounds, tachycardia, and fever ≥38°C increases likelihood of pneumonia 1
Role of C-Reactive Protein
- CRP ≥30 mg/L in addition to suggestive symptoms and signs increases the likelihood of pneumonia and strengthens the indication for antibiotics 1
- CRP <10 mg/L or 10-50 mg/L without dyspnea and daily fever makes pneumonia less likely 1
- Measuring CRP is suggested to strengthen both diagnosis and exclusion of pneumonia 1
Chest Radiography Indications
- Order chest radiography when vital signs are abnormal (fever, tachypnea, tachycardia, hypotension) to improve diagnostic accuracy 1
- Do not routinely use antibiotics when vital signs and lung exams are normal, even with isolated auscultatory findings 1, 6
Microbiological Testing
- Routine microbiological testing is not needed for outpatients with suspected pneumonia 1
- Sputum culture and blood cultures are not recommended for patients without risk factors for severity or unusual organisms 1
Monitoring and Follow-Up
Expected Clinical Response
- Fever should resolve within 48 hours of starting appropriate antibiotic therapy 1
- Patients should return if fever does not resolve within 48 hours, as this may indicate treatment failure 1
- Assess clinical response at 48-72 hours after initiating therapy 5
When to Reassess or Change Therapy
- Do not change antibiotics within the first 72 hours unless the patient's clinical state worsens 5
- If no improvement by 48-72 hours, consider investigation for treatment failure including resistant organisms, complications (empyema, abscess), or alternative diagnoses 1
Critical Pitfalls to Avoid
- Do not prescribe antibiotics for acute cough without clinical or radiographic evidence of pneumonia when vital signs and lung exams are normal 1, 7
- Remember that many respiratory infections are viral; only treat when bacterial infection is clinically suspected based on fever, purulent sputum, and systemic signs 1, 5
- Antibiotic therapy must always be active against Streptococcus pneumoniae, which is the most frequently encountered pathogen in community-acquired pneumonia 1
- Patients with comorbidities or recent antibiotic use require broader coverage and should not receive simple aminopenicillin monotherapy 2, 8